Finance1 min read

Guggenheim Names Top Biotech Stock Pick Following JNJ Latest Deal

By · Via Investing.com Markets · Published by Everything Blog

In short

Guggenheim has identified its top biotechnology stock pick in the wake of the latest deal by Johnson & Johnson. Further details regarding the specific company selected and the terms of the transaction were not disclosed.

Key points

  • Guggenheim has identified its top biotechnology stock pick in the wake of the latest deal…: Guggenheim has identified its top biotechnology stock pick in the wake of the latest deal by Johnson & Johnson.
  • Further details regarding the specific company selected and the terms of the transaction…: Further details regarding the specific company selected and the terms of the transaction were not disclosed.
Finance